University of Illinois at Chicago College of Dentistry

Dr. Robert Folberg Joins EyeCare Partners Innovation Center to Lead Clinical Education, Physician Recruitment Efforts

Retrieved on: 
Wednesday, November 2, 2022
Research, Technology, Human Resources, Other Technology, Professional Services, Continuing, Health, Optical, Science, Education, Ophthalmic pathology, National Eye Institute, Illinois Eye and Ear Infirmary, University of Illinois at Chicago College of Dentistry, Research, Ophthalmology, Physician, Innovation Center station, Optometry, Head, ECP, House Ear Institute, Oakland University, Partner, University, Patient, Education, Pathology, Medicine, Hospital

EyeCare Partners (ECP), the nations leading provider of clinically integrated eye care, has named Robert Folberg, M.D., as Vice President of Education as part of the companys newly launched Innovation Center.

Key Points: 
  • EyeCare Partners (ECP), the nations leading provider of clinically integrated eye care, has named Robert Folberg, M.D., as Vice President of Education as part of the companys newly launched Innovation Center.
  • Many ophthalmologists want to serve patients in a clinical setting, but also want a career that includes clinical research, said Dr. Folberg.
  • EyeCare Partners offers physicians the flexibility to do both as part of a world-class team of optometrists and ophthalmologists.
  • With the launch of the new EyeCare Partners Innovation Center, ECP is focused on promoting an organization-wide culture of collaborative innovation.

Collaborative Wound-Care Strategy Session Planned for Plastic Surgery The Meeting in Boston

Retrieved on: 
Tuesday, October 11, 2022
Physician, Plastic surgery, Wound healing, American Board of Commissioners for Foreign Missions, Education, Strategic planning, American Board of Plastic Surgery, Society, Royal College of Physicians and Surgeons of Canada, Patient, Royal college, University of Illinois at Chicago College of Dentistry, MBA, Research, Surgeon, American Society of Plastic Surgeons, University, Convention center, Curriculum, Boston Convention and Exhibition Center, MD, Obesity, Diabetes, College, EDT, Skin, ASPS, Plastic, Ageing, American College, University of Illinois Hospital & Health Sciences System, Leadership, Veterinary medicine, Medicine, Dentistry

BOSTON, Oct. 11, 2022 /PRNewswire/ -- The American Society of Plastic Surgery (ASPS) and the American College of Wound Healing and Tissue Repair (ACWHTR) will hold a joint strategic planning meeting on Oct. 27 in Boston to discuss advanced fellowship training in wound healing and tissue repair.

Key Points: 
  • The goal of the meeting is to improve patient outcomes across many settings by establishing a formal, consistent educational curriculum.
  • The strategic planning and ASPS/ACWHTR Wound Care Fellowship launch meeting will take place at 1:15 p.m. EDT at the Boston Convention & Exhibition Center on Oct. 27, during Plastic Surgery The Meeting in Boston.
  • The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world.
  • Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

EyeCare Partners Expands Footprint in Northern Ohio with Three Additional Practices

Retrieved on: 
Tuesday, October 11, 2022
Hospitals, Optical, Health, Surgery, LinkedIn, ASC, Â, Ophthalmology, ECP, Partner, RSO, Patient, Clinic, University of Illinois at Chicago College of Dentistry, Cleveland Magazine, Drexel University College of Medicine, Partnership, University, Cornea, Optometry, Cataract, Case Western Reserve University, Outpatient surgery, Veterinary medicine, Hospital

EyeCare Partners (ECP), the nations leading provider of clinically integrated eye care, announced that it has expanded its presence in Northern Ohio through a partnership with Novus Clinic, Corrective Eye Center and Retina Specialists of Ohio (RSO).

Key Points: 
  • EyeCare Partners (ECP), the nations leading provider of clinically integrated eye care, announced that it has expanded its presence in Northern Ohio through a partnership with Novus Clinic, Corrective Eye Center and Retina Specialists of Ohio (RSO).
  • As EyeCare Partners continues to grow, we remain focused on providing seamless care for all patient needs from comprehensive eye exams to specialty surgery," said Kari Holloway, Ph.D., ECPs Ophthalmology Division President.
  • Novus Clinic, Corrective Eye Center and Retina Specialists of Ohio are three specialty practices that will further support our goal of providing the best service to patients.
  • EyeCare Partners is the nations leading provider of clinically integrated eye care.

Childhood Lead Poisoning in the Chicago Area: The Latest Evidence and Public Health Approaches

Retrieved on: 
Friday, September 16, 2022
Institute, MPH, Lead poisoning, Health, University of Illinois Urbana-Champaign, Dean (education), EPA, Public health, United States Environmental Protection Agency, Environment, Program, Occupational medicine, FACPM, BLL, Environmental medicine, Regius Professor, Champaign County, Illinois, Population health, Lead, Research, University of Illinois at Chicago College of Dentistry, ISCB Senior Scientist Award, University, Communication, School, NIH, Atmosphere, Education, Medicine, Soil, MD, DDS

CHICAGO, Sept. 16, 2022 /PRNewswire/ -- The Institute of Medicine of Chicago (IOMC) is pleased to announce its latest webinar 'Childhood Lead Poisoning in the Chicago Area: The Latest Evidence and Public Health Approaches. This program is part of IOMC's programmatic series Public Health, Population Health, and Community Health – Reducing Health Disparities. The webinar will be held on Fri., Sept. 23, 2022 at 12:00 PM CT-1:00 PM CT. The program is open to all and is free. Registration is required, visit this page .

Key Points: 
  • (Our World Data 1.2022)
    CHICAGO, Sept. 16, 2022 /PRNewswire/ -- The Institute of Medicine of Chicago (IOMC) is pleased to announce its latest webinar 'Childhood Lead Poisoning in the Chicago Area: The Latest Evidence and Public Health Approaches.
  • This program is part of IOMC's programmatic series Public Health, Population Health, and Community Health Reducing Health Disparities.The webinar will be held on Fri., Sept. 23, 2022 at 12:00 PM CT-1:00 PM CT.
  • Urban soils contaminated with lead contribute to elevated blood lead levels (BLLs) in young children.
  • In addition, the air and environment may have an elevated lead level contributing to and creating overall lead exposure.

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Retrieved on: 
Wednesday, September 7, 2022
University of Edinburgh, Patient safety, Audit committee, University, Royal college, CEO, Technology, CSE, Pain, Lists of diseases, Psilocybin, Disorder, Corporate governance, PTSD, Professor, Macdonald, Compensation, Option, Sale, Board, Parexel, Policy, Head, Senior, Bachelor of Medicine, Bachelor of Surgery, Patent, University of Illinois at Chicago College of Dentistry, Organization, Depression, Psychiatry, Canadian Securities Exchange, GLOBE, Eli Lilly, Company, Bright Minds In Action Learning Village, Champaign County, Illinois, News, ROI, Medicinal chemistry, NOT, Raj Persaud, Epilepsy, Director, Stock, Drug development, COVID, Eli Lilly and Company, FOR, Pharmaceutical industry, Security (finance), Medicine, Lundbeck

VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced the appointment of Doug Williamson to the Company’s Board of Directors (the “Board”). Dr. Williamson will serve on the Compensation, Nominating and Corporate Governance, and Audit Committees as an independent director. Concurrently, Dr. Alan Kozikowski has resigned from the Board.

Key Points: 
  • Dr. Williamson will serve on the Compensation, Nominating and Corporate Governance, and Audit Committees as an independent director.
  • Dr. Williamson has an impressive track record in developing safe and profitable pharmaceuticals and biotechnologies for global industry leaders.
  • With his reputation for generating quality results while improving ROI and building high-performance, engaged teams, we are thrilled to welcome Dr. Williamson to the Board, stated Ian McDonald, CEO and Co-founder of Bright Minds Biosciences.
  • BMB-101 is the subject of a patent licensed by Bright Minds Biosciences from the University of Illinois.

Dr. Cameron Lewis, First Healthcare Provider to Guest Speak at VIP Mastermind Conference

Retrieved on: 
Friday, July 15, 2022
Oral and maxillofacial surgery, Primary health care, Patient, Historic Grand Hotels on the Mississippi Gulf Coast, Chief Dental Officer (Canada), DDS, College, University of Illinois at Chicago College of Dentistry, Trial balance, Industry, Howard University Hospital, Autism, Instagram, Cameron, Awareness, New York Medical College, Dental surgery, Dentistry, Hudson Valley

New York, New York--(Newsfile Corp. - July 15, 2022) - Dr. Cameron Lewis, a traveling oral maxillofacial surgeon, will be attending the VIP Mastermind conference in Miami, FL in late August.

Key Points: 
  • New York, New York--(Newsfile Corp. - July 15, 2022) - Dr. Cameron Lewis, a traveling oral maxillofacial surgeon, will be attending the VIP Mastermind conference in Miami, FL in late August.
  • Of the event's multimillionaire A-list speakers who will also be in attendance, none of them are healthcare providers.
  • Dr. Lewis will be the first expert of the industry to bring his knowledge into this space.
  • He's hoping to share more about his journey with other like-minded professionals at the VIP Mastermind conference , which will be held August 26th in Miami, FL.

Eduardo Smith Singares, MD, FACS, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, May 17, 2022
Stony Brook University, Fellow, MBA, Education, Rush University Medical Center, Hospital, Medicine, American College, University of Illinois at Chicago College of Dentistry, Clinical, Multimedia, Patient, Washington University School of Medicine, Injury, Association, Society, Social, Association for Academic Surgery, Malteser International, Medical director, General surgery, Johns Hopkins Hospital, Critical Care Medicine (journal), Fellowship of the Royal Colleges of Surgeons, University, University of Illinois Hospital & Health Sciences System, Division, Inferior vena cava, Elson S. Floyd College of Medicine, Social Security, FACS, Medical degree, Trauma, Gastrointestinal tract, University of Panama, Elective surgery, Surgery, Society of Critical Care Medicine, Continental, Dentistry, MD

In his work as a Trauma Surgeon, Dr. Smith Singares helps patients who have had traumatic accidents or injuries, gunshot wounds, or auto accident victims.

Key Points: 
  • In his work as a Trauma Surgeon, Dr. Smith Singares helps patients who have had traumatic accidents or injuries, gunshot wounds, or auto accident victims.
  • Dr. Smith Singares is board-certified in general surgery and critical surgical care and will be testing to become board certified in neurocritical care very soon.
  • On a personal note, Dr. Smith Singares is a Knight of the Order of Malta (Maltese International).
  • Dr. Smith Singares would like to dedicate this honorable recognition to his wife of 23 years, Mrs. Izaskun Eglesias, MD, MBA, and their three children.

Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry

Retrieved on: 
Tuesday, May 17, 2022
Biotechnology, General Health, Health, Pharmaceutical, Oncology, Senior, GSK, Inflammation, Janssen, Doctor of Philosophy, University of Illinois at Chicago College of Dentistry, Disease, Wyeth, Patient, Science, Therapy, Imperial College London, Molecular Cancer Research, Central nervous system disease, Duke University Hospital, CNS, Partnership, Neurodegeneration, UCB, RNA, HIV disease progression rates, University, REMIX, Protein, EZH2, Acquisition, LLC, Drug discovery, Quantum, Cancer, Medicinal chemistry, AstraZeneca, Lists of diseases, Pharmaceutical industry, Fine chemical, Monte Civetta, Biology, Chemistry

Its an exciting time for the company as we move toward the clinic, and Jesse and Sue bring tremendous translational drug development experience across multiple therapeutic areas.

Key Points: 
  • Its an exciting time for the company as we move toward the clinic, and Jesse and Sue bring tremendous translational drug development experience across multiple therapeutic areas.
  • They, like others on the Civetta leadership team, have firsthand experience leading programs into the clinic and beyond.
  • Jesse Smith, Ph.D., has over 20 years of experience advancing novel science, drug discovery, and therapeutics across the biotech and pharma industry.
  • Civetta is a biotechnology company focused on the development of therapies that target beta-propeller domains to treat cancer and other diseases.

ASTCT Presents Distinguished Honors at the 2022 Tandem Meetings

Retrieved on: 
Wednesday, April 27, 2022
University of Illinois at Chicago College of Dentistry, University of Washington School of Medicine, Twitter, Fred Hutchinson Cancer Research Center, Research, New, Chicago, Hospital, Petersdorf, List of lifetime achievement awards, Education, Program, Immunogenetics, Review, Blood, BMT, Mike Reese, Division, Transplant, HLA, Physician, University, Time, Association, Medical device, Hematology

Effie Petersdorf, M.D., was honored with the 2022 ASTCT Lifetime Achievement Award.

Key Points: 
  • Effie Petersdorf, M.D., was honored with the 2022 ASTCT Lifetime Achievement Award.
  • The 2022 ASTCT Public Service Award was presented to Damiano Rondelli, M.D.
  • The ASTCT Board of Directors recognized James W. Young, M.D., with the 2022 ASTCT Special Recognition for his outstanding contributions to the New Investigator Awards program.
  • For more information about ASTCT, visit www.astct.org and follow ASTCT on Twitter @ASTCT .

Dr. Adam Saltman Appointed Chief Medical Officer of ChemImage

Retrieved on: 
Tuesday, April 5, 2022
Method, Risk, Attack on Titan, University, University of Illinois at Chicago College of Dentistry, Fellowship of the Royal Colleges of Surgeons, Hotel manager, Leadership, Machine learning, Health, Multimedia, Health informatics, Quality, American College of Cardiology, Research, Doctor of Philosophy, Columbia University, American College of Chest Physicians, American Heart Association, Chemical imaging, AI, Physician, Food, Harvard University, MD, Artificial intelligence, Industry, Technology, Safety, Knowledge, MS, Society, US Foods, American College, Awareness, Algorithm, Medical device, FDA, American Society for Quality, Patient, Decision-making, Management, Electrophysiology, Biochemistry

 PITTSBURGH, April 5, 2022 /PRNewswire/ --ChemImage, a leader in molecular chemical imaging, today announced the appointment of Adam Saltman, MD, PhD as its Chief Medical Officer. In this role, Dr. Saltman will provide leadership and direction to Clinical Affairs while expanding the approach for the company's patented technology in medical applications.  He will also serve on ChemImage's Executive Management Team, where his experience as a board-certified physician and healthcare technology innovator will bring invaluable insights and knowledge to the organization.

Key Points: 
  • PITTSBURGH, April 5, 2022 /PRNewswire/ --ChemImage, a leader in molecular chemical imaging, today announced the appointment of Adam Saltman, MD, PhD as its Chief Medical Officer.
  • He was previously the Chief Medical Officer at digital health company, Eko, where he excelled in the advancement of Artificial Intelligence and Machine Learning in healthcare.
  • Prior to Eko, Dr. Saltman practiced cardiothoracic surgery until 2013 when he joined the US Food and Drug Administration (FDA) as a Medical Officer.
  • "We are excited by the addition of Dr. Saltman to the ChemImage team," ChemImage President and Founder, Patrick Treado stated.